142 related articles for article (PubMed ID: 15017644)
1. A collaborative health care model for the treatment of irritable bowel syndrome.
Gerson CD; Gerson MJ
Clin Gastroenterol Hepatol; 2003 Nov; 1(6):446-52. PubMed ID: 15017644
[TBL] [Abstract][Full Text] [Related]
2. Collaborative health for IBS.
Mayer EA
Clin Gastroenterol Hepatol; 2003 Nov; 1(6):423-4. PubMed ID: 15017640
[No Abstract] [Full Text] [Related]
3. Integrated medical-psychiatric outpatient care in functional gastrointestinal disorders improves outcome: a pilot study.
Kruimel J; Leue C; Winkens B; Marcus D; Schoon S; Dellink R; van Os J; Masclee A
Eur J Gastroenterol Hepatol; 2015 Jun; 27(6):721-7. PubMed ID: 25831133
[TBL] [Abstract][Full Text] [Related]
4. Bulking agents, antispasmodic and antidepressant medication for the treatment of irritable bowel syndrome.
Quartero AO; Meineche-Schmidt V; Muris J; Rubin G; de Wit N
Cochrane Database Syst Rev; 2005 Apr; (2):CD003460. PubMed ID: 15846668
[TBL] [Abstract][Full Text] [Related]
5. Protocol for a randomized controlled study of Iyengar yoga for youth with irritable bowel syndrome.
Evans S; Cousins L; Tsao JC; Sternlieb B; Zeltzer LK
Trials; 2011 Jan; 12():15. PubMed ID: 21244698
[TBL] [Abstract][Full Text] [Related]
6. The interface of psychiatry and irritable bowel syndrome.
Folks DG
Curr Psychiatry Rep; 2004 Jun; 6(3):210-5. PubMed ID: 15142474
[TBL] [Abstract][Full Text] [Related]
7. Patients with irritable bowel syndrome-diarrhea have lower disease-specific quality of life than irritable bowel syndrome-constipation.
Singh P; Staller K; Barshop K; Dai E; Newman J; Yoon S; Castel S; Kuo B
World J Gastroenterol; 2015 Jul; 21(26):8103-9. PubMed ID: 26185382
[TBL] [Abstract][Full Text] [Related]
8. Effect of nurse-led gut-directed hypnotherapy upon health-related quality of life in patients with irritable bowel syndrome.
Smith GD
J Clin Nurs; 2006 Jun; 15(6):678-84. PubMed ID: 16684163
[TBL] [Abstract][Full Text] [Related]
9. An Open-Label Pilot Study of Duloxetine in Patients With Irritable Bowel Syndrome and Comorbid Major Depressive Disorder.
Lewis-Fernández R; Lam P; Lucak S; Galfalvy H; Jackson E; Fried J; Rosario M; de la Cruz AA; Sánchez-Lacay A; Díaz S; Schneier F
J Clin Psychopharmacol; 2016 Dec; 36(6):710-715. PubMed ID: 27755218
[TBL] [Abstract][Full Text] [Related]
10. An Intervention for Person-Centered Support in Irritable Bowel Syndrome: Development and Pilot Study.
Björkman I; Ringström G; Simrén M; Myrgren J; Jakobsson Ung E
Gastroenterol Nurs; 2019; 42(4):332-341. PubMed ID: 31365423
[TBL] [Abstract][Full Text] [Related]
11. Probiotic Bifidobacterium longum NCC3001 Reduces Depression Scores and Alters Brain Activity: A Pilot Study in Patients With Irritable Bowel Syndrome.
Pinto-Sanchez MI; Hall GB; Ghajar K; Nardelli A; Bolino C; Lau JT; Martin FP; Cominetti O; Welsh C; Rieder A; Traynor J; Gregory C; De Palma G; Pigrau M; Ford AC; Macri J; Berger B; Bergonzelli G; Surette MG; Collins SM; Moayyedi P; Bercik P
Gastroenterology; 2017 Aug; 153(2):448-459.e8. PubMed ID: 28483500
[TBL] [Abstract][Full Text] [Related]
12. Self-regulation evaluation of therapeutic yoga and walking for patients with irritable bowel syndrome: a pilot study.
Shahabi L; Naliboff BD; Shapiro D
Psychol Health Med; 2016; 21(2):176-88. PubMed ID: 26086986
[TBL] [Abstract][Full Text] [Related]
13. Development of the Diary for Irritable Bowel Syndrome Symptoms to Assess Treatment Benefit in Clinical Trials: Foundational Qualitative Research.
Fehnel SE; Ervin CM; Carson RT; Rigoni G; Lackner JM; Coons SJ;
Value Health; 2017 Apr; 20(4):618-626. PubMed ID: 28408004
[TBL] [Abstract][Full Text] [Related]
14. Predictive factors of irritable bowel syndrome improvement: 1-year prospective evaluation in 400 patients.
Mearin F; Badía X; Balboa A; Benavent J; Caballero AM; Domínguez-Muñoz E; Garrigues V; Piqué JM; Roset M; Cucala M; Figueras M;
Aliment Pharmacol Ther; 2006 Mar; 23(6):815-26. PubMed ID: 16556184
[TBL] [Abstract][Full Text] [Related]
15. Preliminary study of a self-administered treatment for irritable bowel syndrome: comparison to a wait list control group.
Sanders KA; Blanchard EB; Sykes MA
Appl Psychophysiol Biofeedback; 2007 Jun; 32(2):111-9. PubMed ID: 17564825
[TBL] [Abstract][Full Text] [Related]
16. Pilot-RCT of an integrative group therapy for patients with refractory irritable bowel syndrome (ISRCTN02977330).
Berens S; Stroe-Kunold E; Kraus F; Tesarz J; Gauss A; Niesler B; Herzog W; Schaefert R
J Psychosom Res; 2018 Feb; 105():72-79. PubMed ID: 29332637
[TBL] [Abstract][Full Text] [Related]
17. Treatment of irritable bowel syndrome with a novel colonic irrigation system: a pilot study.
Hsu HH; Leung WH; Hu GC
Tech Coloproctol; 2016 Aug; 20(8):551-7. PubMed ID: 27194235
[TBL] [Abstract][Full Text] [Related]
18. Duloxetine in the treatment of irritable bowel syndrome: an open-label pilot study.
Brennan BP; Fogarty KV; Roberts JL; Reynolds KA; Pope HG; Hudson JI
Hum Psychopharmacol; 2009 Jul; 24(5):423-8. PubMed ID: 19548294
[TBL] [Abstract][Full Text] [Related]
19. Irritable bowel syndrome: a comparison of subtypes.
Rey de Castro NG; Miller V; Carruthers HR; Whorwell PJ
J Gastroenterol Hepatol; 2015 Feb; 30(2):279-85. PubMed ID: 25091059
[TBL] [Abstract][Full Text] [Related]
20. Self-help guidebook improved quality of life for patients with irritable bowel syndrome.
Schneider A; Rosenberger S; Bobardt J; Bungartz-Catak J; Atmann O; Haller B; Kennedy A; Enck P
PLoS One; 2017; 12(7):e0181764. PubMed ID: 28742808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
